Skip to main content

Advertisement

Log in

Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Circulating endothelial progenitor cells (EPCs) are bone marrow-derived stem cells able to migrate to sites of damaged endothelium and differentiate into endothelial cells, thereby contributing to vascular repair. Recent studies demonstrated a reduction of EPCs in patients with diabetes mellitus or erectile dysfunction (ED). The aim of this study was to evaluate the circulating levels of different EPCs phenotypes and their relation with testosterone levels in young type 1 diabetic patients with ED. We studied 118 consecutively type 1 diabetic patients and 60 age-matched healthy controls. Erectile function was assessed by completing the International Index of Erectile Function (IIEF-5) and EPCs levels by flow cytometry. Testosterone concentrations were evaluated in all the study population. We identified 38 diabetic patients with ED (Group 1) and 80 patients without ED (Group 2). CD34+KDR+CD133+ cells were significantly lower in patients in Group 1 as compared with those in Group 2 [median and interquartile range, n/106 events, 12 (6–16) vs. 18 (13–22), P < 0.001)]. In all participants in the study, there was a significant correlation between circulating CD34+KDR+CD133+ cells and testosterone levels (r = 0.410, P < 0.001), which was highest in Group 1, intermediate in Group 2, and lowest in Group 3 (controls). There was a significant correlation between IIEF-5 score and both CD34+KDR+ (r = 0.459, P = 0.003) and CD34+KDR+CD133+ (r = 0.316, P = 0.050) cells among patients of Group 1, as well as between testosterone levels and most of the EPCs phenotypes. Finally, multivariate regression analysis identified levels of circulating CD34+KDR+ cells as an independent risk factor for ED (β-coefficient 0.348, P = 0.007). In conclusion, type 1 diabetic patients with ED show reduced levels of CD34+KDR+CD133+ cells, whose number correlates with IIEF. Further studies are needed to fully understand the exact mechanisms by which testosterone regulates vascular homeostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. D. Fedele, C. Coscelli, F. Santeusanio, A. Bortolotti, L. Chatenoud, E. Colli, M. Landoni, F. Parazzini, Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 21, 1973–1977 (1998)

    Article  CAS  PubMed  Google Scholar 

  2. C.G. Bacon, F.B. Hu, E. Giovannucci, D.B. Glasser, M.A. Mittleman, E.B. Rimm, Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 25, 1458–1463 (2002)

    Article  PubMed  Google Scholar 

  3. M. Buysschaert, J.L. Medina, M. Bergman, A. Shah, J. Lonier, Prediabetes and associated disorders. Endocrine (2014). doi:10.1007/s12020-014-0436-2

    PubMed  Google Scholar 

  4. A. Sansone, F. Romanelli, D. Gianfrilli, A. Lenzi, Endocrine evaluation of erectile dysfunction. Endocrine 46, 423–430 (2014)

    Article  CAS  PubMed  Google Scholar 

  5. S.C. Siu, S.K. Lo, K.W. Wong, K.M. Ip, Y.S. Wong, Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet. Med. 18, 732–738 (2001)

    Article  CAS  PubMed  Google Scholar 

  6. L.S. Malavige, S.D. Jayaratne, S.T. Kathriarachchi, S. Sivayogan, D.J. Fernando, J.C. Levy, Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. J. Sex. Med. 5, 2125–2134 (2008)

    PubMed  Google Scholar 

  7. F. Giugliano, M.I. Maiorino, G. Bellastella, M. Gicchino, D. Giugliano, K. Esposito, Determinants of erectile dysfunction in type 2 diabetes. Int. J. Impot. Res. 22, 204–209 (2010)

    Article  CAS  PubMed  Google Scholar 

  8. H. Sasaki, H. Yamasaki, K. Ogawa, K. Nanjo, R. Kawamori, Y. Iwamoto, S. Katayama, M. Shirai, Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res. Clin. Pract. 70, 81–89 (2005)

    Article  PubMed  Google Scholar 

  9. V.S. Thorve, A.D. Kshirsagar, N.S. Vyawahare, V.S. Joshi, K.G. Ingale, R.J. Mohite, Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J. Diabetes Complicat. 25, 129–136 (2011)

    Article  PubMed  Google Scholar 

  10. J.Y. Dong, Y.H. Zhang, L.Q. Qin, Erectile dysfunction and risk of cardiovascular disease meta-analysis of prospective cohort studies. J. Am. Coll. Cardiol. 58, 1378–1385 (2011)

    Article  PubMed  Google Scholar 

  11. G. Gandaglia, A. Salonia, N. Passoni, P. Montorsi, A. Briganti, F. Montorsi, Erectile dysfunction as a cardiovascular risk factor in patients with diabetes. Endocrine 43, 285–292 (2013)

    Article  CAS  PubMed  Google Scholar 

  12. S.J. Turek, S.M. Hastings, J.K. Sun, G.L. King, H.A. Keenan, Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes. Diabetes Care 36, 3222–3226 (2013)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. K. Esposito, M. Ciotola, F. Giugliano, L. Sardelli, F. Giugliano, M.I. Maiorino, F. Beneduce, M. De Sio, D. Giugliano, Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J. Sex. Med. 5, 1436–1442 (2008)

    Article  PubMed  Google Scholar 

  14. D.R. Meldrum, J.C. Gambone, M.A. Morris, D.A. Meldrum, K. Esposito, L.J. Ignarro, The link between erectile and cardiovascular health: the canary in the coal mine. Am. J. Cardiol. 15, 599–606 (2011)

    Article  Google Scholar 

  15. D. Burger, R.M. Touyz, Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J. Am. Soc. Hypertens. 6, 85–99 (2012)

    Article  CAS  PubMed  Google Scholar 

  16. C. Urbich, S. Dimmeler, Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 20, 343–353 (2004)

    Article  Google Scholar 

  17. M. Zhang, A.B. Malik, J. Rehman, Endothelial progenitor cells and vascular repair. Curr. Opin. Hematol. 21, 224–228 (2014)

    Article  PubMed Central  PubMed  Google Scholar 

  18. J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, A.A. Quyyumi, T. Finkel, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593–600 (2003)

    Article  PubMed  Google Scholar 

  19. G.P. Fadini, E. Boscaro, S. de Kreutzenberg, C. Agostini, F. Seeger, S. Dimmeler, A. Zeiher, A. Tiengo, A. Avogaro, Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 33, 1097–1102 (2010)

    Article  PubMed Central  PubMed  Google Scholar 

  20. T. Hörtenhuber, B. Rami-Mehar, M. Satler, K. Nagl, C. Höbaus, F. Höllerl, R. Koppensteiner, G. Schernthaner, E. Schober, G.H. Schernthaner, Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care 36, 1647–1653 (2013)

    Article  PubMed Central  PubMed  Google Scholar 

  21. C. Foresta, N. Caretta, A. Lana, A. Cabrelle, G. Palu, A. Ferlin, Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int. J. Impot. Res. 17, 288–290 (2005)

    Article  CAS  PubMed  Google Scholar 

  22. S. Dimmeler, A.M. Zeiher, Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J. Mol. Med. 82, 671–677 (2004)

    Article  PubMed  Google Scholar 

  23. C. Foresta, D. Zuccarello, L. De Toni, A. Garolla, N. Caretta, A. Ferlin, Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clin. Endocrinol. 68, 284–289 (2008)

    CAS  Google Scholar 

  24. J. Cai, Y. Hong, C. Weng, C. Tan, J. Imperato-McGinley, Y.S. Zhu, Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. Am. J. Physiol. Heart Circ. Physiol. 300, H1210–H1221 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. R.C. Rosen, J.C. Cappelleri, M.D. Smith, J. Lipsky, B.M. Pena, Development and evaluation of an abridged, 5-item version of the International Index of erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 11, 319–326 (1999)

    Article  CAS  PubMed  Google Scholar 

  26. M.I. Maiorino, E. Della Volpe, L. Olita, G. Bellastella, D. Giugliano, K. Esposito, Glucose variability inversely associates with endothelial progenitor cells in type 1 diabetes. Endocrine. doi:10.1007/s12020-014-0277-z (2014)

  27. F.C. Wu, A. Tajar, J.M. Beynon, S.R. Pye, A.J. Silman, J.D. Finn, T.W. O’Neill, G. Bartfai, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, M.E. Lean, N. Pendleton, M. Punab, Boonen Vanderschueren, D., Labrie, F., Huhtaniemi, I.T., EMAS Group.: Identification of late-onset hypogonadism in middleaged and elderly men. N. Engl. J. Med. 363, 123–135 (2010)

    Article  CAS  PubMed  Google Scholar 

  28. M. Murata, H. Tamemoto, T. Otani, S. Jinbo, N. Ikeda, M. Kawakami, S.E. Ishikawa, Endothelial impairment and bone marrow-derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction. J. Diabetes Investig. 20, 526–533 (2012)

    Article  Google Scholar 

  29. S. La Vignera, R.A. Condorelli, S. Tumino, M. Di Mauro, E. Vicari, A.E. Calogero, Original evaluation of endothelial dysfunction in men with erectile dysfunction and metabolic syndrome. Int. J. Impot. Res. 24, 150–154 (2012)

    Article  PubMed  Google Scholar 

  30. S. La Vignera, R. Condorelli, E. Vicari, R. D’Agata, A. Calogero, Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy. Aging Male 14, 183–189 (2011)

    Article  PubMed  Google Scholar 

  31. R.A. Condorelli, A.E. Calogero, E. Vicari, L. di Pino, F. Giacone, L. Mongioì, S. la Vignera, Arterial erectile dysfunction and peripheral arterial disease: reliability of a new phenotype of endothelial progenitor cells and endothelial microparticles. J. Androl. 33, 1268–1675 (2012)

    Article  CAS  PubMed  Google Scholar 

  32. S. Sen, S.P. McDonald, P.T. Coates, C.S. Bonder, Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin. Sci. (Lond.) 120, 263–283 (2011)

    CAS  Google Scholar 

  33. K. Esposito, M. Ciotola, M.I. Maiorino, F. Giugliano, R. Autorino, M. De Sio, E. Jannini, A. Lenzi, D. Giugliano, Circulating CD34+KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men. J. Sex. Med. 6, 107–114 (2009)

    Article  PubMed  Google Scholar 

  34. N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Böhm, G. Nickenig, Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 8, 999–1007 (2005)

    Article  Google Scholar 

  35. C. Schmidt-Lucke, L. Rössig, S. Fichtlscherer, M. Vasa, M. Britten, U. Kämper, S. Dimmeler, A.M. Zeiher, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 7, 2981–2987 (2005)

    Article  Google Scholar 

  36. G.P. Fadini, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, S.V. de Kreutzenberg, Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37, 2277–2282 (2006)

    Article  CAS  PubMed  Google Scholar 

  37. K. Eisermann, C.J. Broderick, A. Bazarov, M.M. Moazam, G.C. Fraizer, Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site. Mol. Cancer. 12, 7 (2013)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. R. Liu, L. Ding, M.H. Yu, H.Q. Wang, W.C. Li, Z. Cao, P. Zhang, B.C. Yao, J. Tang, Q. Ke, T.Z. Huang, Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells. Endocrine 46, 634–643 (2014)

    Article  CAS  PubMed  Google Scholar 

  39. E. García-Cruz, A. Leibar-Tamayo, J. Romero, M. Piqueras, P. Luque, O. Cardeñosa, A. Alcaraz, Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med. 10, 2529–2538 (2013)

    PubMed  Google Scholar 

  40. C. Foresta, N. Caretta, A. Lana, L. De Toni, A. Biagioli, A. Ferlin, A. Garolla, Reduced number of circulating endothelial progenitor cells in hypogonadal men. J. Clin. Endocrinol. Metab. 91, 4599–4602 (2006)

    Article  CAS  PubMed  Google Scholar 

  41. G.P. Fadini, M. Albiero, A. Cignarella, C. Bolego, C. Pinna, E. Boscaro, E. Pagnin, R. De Toni, S. de Kreutzenberg, C. Agostini, A. Avogaro, Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clin. Sci. (Lond). 7, 355–364 (2009)

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Filomena Castaldo and Dr. Laura Olita for technical support and collection of data.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Ida Maiorino.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maiorino, M.I., Bellastella, G., Petrizzo, M. et al. Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction. Endocrine 49, 415–421 (2015). https://doi.org/10.1007/s12020-014-0478-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0478-5

Keywords

Navigation